Oral contraceptives, parity, and cervical cancer
- 1 March 2002
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 359 (9312) , 1080-1081
- https://doi.org/10.1016/s0140-6736(02)08125-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort studyPublished by Elsevier ,2001
- Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohortBritish Journal of Cancer, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Determinants of risk of invasive cervical cancer in young women.British Journal of Cancer, 1998
- The epidemiology of cervical carcinogenesisCancer, 1995
- Monthly combined injectable contraceptives and neoplasiaContraception, 1994
- Oral contraceptives and cervical neoplasiaContraception, 1991
- PARITY AS A RISK FACTOR FOR CERVICAL CANCERAmerican Journal of Epidemiology, 1989
- IMPORTANCE OF THE MALE FACTOR IN CANCER OF THE CERVIXThe Lancet, 1982
- Epidemiology of cancer of the cervix. II. Marital and coital factors in cervical cancer.American Journal of Public Health and the Nations Health, 1967